| Patents for C07C 219 - Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton (3,521) |
|---|
| 06/11/2003 | CN1423641A Quaternary salts of N-substituted cyclic or acyclic amines as pharmaceuticals |
| 06/10/2003 | US6576684 Ammonium, phosphonium or sulfonium containing oligomers or polymers; controlled molecular weight, low polydispersity and a vinyl or dienyl end group; polymeric precursors and addi-tives |
| 06/10/2003 | CA2055670C Retroviral protease inhibiting compounds |
| 06/05/2003 | US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 06/05/2003 | US20030104311 At least one of the hydroxy groups carries a tert-alkoxycarbonyl group; reacted with dicarboxylic acids to form polyamides; cyclization |
| 06/03/2003 | US6573405 Ionic liquids |
| 05/29/2003 | US20030100679 Reacting 1,3-bis/dialkylamino/2-hydroxypropane with (meth)acrylic anhydride in triethylamine in presence of an stabilizer, quaternizing the compound |
| 05/29/2003 | US20030100616 Administering to a patient for the treatment and/or prophylaxis an effective amount of 3-amino-propoxy derivative as a potent, beta-1-sepcific beta blocker whith a short duration of action in the systemic circulation |
| 05/29/2003 | US20030100598 Novel esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl |
| 05/29/2003 | US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 05/27/2003 | US6569504 Mesogenic materials with anomalous birefringence dispersion and high second order susceptibility (X(2)) |
| 05/27/2003 | US6569411 Deodoring, microbiocides, marking odors |
| 05/22/2003 | WO2003042162A1 Prodrugs of antidepressants and their use for treating depressions |
| 05/22/2003 | US20030096858 The parent drug compound is modified by forming one or more of predetermined chemical arrangement within parent drug structure for programming specific course and rate of metabolism for drug that leads to inactive nontoxic metabolite |
| 05/22/2003 | US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 05/22/2003 | US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/21/2003 | EP0830336B1 Process for the preparation of tertiary aminocarbonates and aminoethers |
| 05/21/2003 | CN1419006A Preparation of high content (alkyl fatty ester) dihyamine compound from trihydroxy ethylamine |
| 05/08/2003 | US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol |
| 05/07/2003 | EP1307424A2 Method for making aqueous solutions of (meth)acryloyloxyethylbenzyldimethylammonium chlorides |
| 05/07/2003 | EP0940387B1 Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same |
| 05/01/2003 | WO2003035599A1 Quarternary ammonium compounds and their use as antimuscarinic agents |
| 05/01/2003 | WO2002026701A3 Ionic liquids and their use as solvents |
| 05/01/2003 | US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/30/2003 | CN1414946A Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxy cyclohexyl) phenyl |
| 04/24/2003 | WO2003032969A2 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications |
| 04/24/2003 | US20030078417 For protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents; for therapy of phospholipase mediated injury, injury due to oxidation, and inflammation |
| 04/24/2003 | US20030078339 Degradable cross-linking agents and cross-linked network polymers formed therewith |
| 04/24/2003 | CA2463624A1 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications |
| 04/23/2003 | CN1413185A Substitued 1 and 2 naphthol mannich bases |
| 04/23/2003 | CN1413181A Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand |
| 04/16/2003 | EP1302458A1 Ester derivatives |
| 04/16/2003 | EP1301497A1 Colchinol derivatives as vascular damaging agents |
| 04/16/2003 | EP1301463A1 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
| 04/09/2003 | EP1299345A1 Method for preparing amino alkyl(meth)acrylates |
| 04/02/2003 | EP1077924B1 Ethoxylated quaternary ester compounds |
| 03/26/2003 | EP1296142A2 Calcium receptor active molecules |
| 03/20/2003 | WO2003022796A1 Synthesis of alkylaminoalkyl (meth)acrylate by transesterification |
| 03/19/2003 | CN1403455A Synthesis of 2-oxazolidone derivate by one still process |
| 03/18/2003 | CA2141334C Cationic lipids |
| 03/13/2003 | US20030050417 Method for making monomers with two quarternary amino group and (co)polymers obtained from said monomers |
| 03/13/2003 | US20030050316 An amine compound of phenyl or hetero ring for treating Alzheimer's disease |
| 03/13/2003 | US20030049310 Genetic enginnering; inducing antibodies |
| 03/12/2003 | EP1289362A1 Use of amine compounds with improved biodegradability as adjuvants for pesticides and fertilisers |
| 03/12/2003 | EP0672031B1 Catechol diethers as selective pde iv inhibitors |
| 03/12/2003 | CN1401628A Process for preparing substd. (or unsubstd.) aminoalkyl acrylate |
| 03/05/2003 | EP1287006A1 Antitumoral compounds |
| 03/05/2003 | EP1286952A2 Ester quaternary mixtures |
| 02/26/2003 | EP1284954A1 Method for the production of esters of unsaturated carboxylic acids |
| 02/26/2003 | EP1284730A1 Aralkyl ester soft drugs |
| 02/25/2003 | US6525068 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 02/18/2003 | US6521782 Method for making aqueous solutions of unsaturated quaternary ammonium salts |
| 02/18/2003 | US6521589 Quaternary fatty acid triethanolamine ester salts and their use as fabric softeners |
| 02/18/2003 | US6521431 Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments |
| 02/13/2003 | WO2002096855A3 Anticholinergic compounds and methods of use |
| 02/13/2003 | US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 02/11/2003 | US6518326 Open chain alkoxyamine compounds and their use as polymerization regulators |
| 02/11/2003 | US6518048 Hydrogenation a isophthalic acid derivative |
| 02/11/2003 | CA2222361C Hydroxypropylated quaternary ammonium derivatives having an ester function, and cosmetic or dermatological compositions containing them |
| 02/06/2003 | US20030028047 Esters of fatty acids and juvenoid alcohols, and a method of their preparation and use |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1280759A1 Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them |
| 02/05/2003 | CN1394855A Substituted heterocyclic compound |
| 01/30/2003 | WO2003008757A1 Additives for inhibiting the formation of gas hydrates |
| 01/30/2003 | WO2003008559A2 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders |
| 01/30/2003 | US20030023113 Process for the manufacture of aqueous solutions of unsaturated quaternary ammonium salts |
| 01/30/2003 | CA2453521A1 Additives for inhibiting the formation of gas hydrates |
| 01/29/2003 | EP1278736A1 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals |
| 01/29/2003 | EP1064253B1 Anti-tumour agents |
| 01/23/2003 | US20030018055 Serine carbonates |
| 01/22/2003 | EP1045891A4 Novel quaternary ammonium compounds, compositions containing them, and uses thereof |
| 01/16/2003 | WO2002034247A3 Anticancer agents based on regulation of protein prenylation |
| 01/15/2003 | EP1274674A1 Choline derivatives for the treatment of alzheimer's disease |
| 01/15/2003 | CN1390828A Acrylate [1,3-bi (dimethyl benzyl ammonium) isopropyl] chloride and production of mixture with other monomers and polymers |
| 01/09/2003 | WO2003002510A1 Crystalline form of a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same |
| 01/09/2003 | US20030008889 Aminoadamantane derivatives as therapeutic agents |
| 01/08/2003 | EP1272147A1 Dental materials with extendable work time, kits, and methods |
| 01/08/2003 | CN1390194A Stable salts of novel derivatives of 3,3-diphenylpropylamines |
| 01/08/2003 | CN1098278C Cinnamic acid derivative |
| 12/31/2002 | US6500849 Administering antiinflammatory, antiproliferative, nootropic or antigrowth agents, such as 6-(1-dodecynyl)-2-pyridine-carboxaldehyde and enantiomorphs to mammals; alzheimers disease |
| 12/25/2002 | CN1097090C Preparation of high di(alkyl fatty ester) quaternary ammonium salt compound from triethanolamine |
| 12/24/2002 | CA2150812C Catechol diethers as selective pde iv inhibitors |
| 12/20/2002 | WO2001098254A1 Method for preparing amino alkyl(meth)acrylates |
| 12/20/2002 | CA2413411A1 Method for preparing amino alkyl(meth)acrylates |
| 12/19/2002 | WO2002100817A2 Method for producing (meth)acrylic acid esters |
| 12/19/2002 | WO2002100815A1 Method for producing (meth)acrylic acid esters |
| 12/19/2002 | WO2002100814A1 Method for producing (meth)acrylic acid esters |
| 12/19/2002 | WO2002100813A2 Modulators of peroxisome proliferator activated receptors |
| 12/19/2002 | US20020193622 For use as additives in chemical amplification photolithography, photoresists |
| 12/19/2002 | US20020193545 Process for manufacturing the chloride of 1,3-bis- (dimethylbenzylammonium) isopropyl, acrylate alone or mixed with other monomers, and corresponding (co) polymers |
| 12/19/2002 | US20020193447 Chemical intermediates for bronchodilators |
| 12/19/2002 | CA2449256A1 Modulators of peroxisome proliferator activated receptors |
| 12/17/2002 | US6495546 Propanolamine derivatives |
| 12/17/2002 | CA2064783C Cytoprotective fatty moiety compounds |
| 12/11/2002 | EP1263849A1 Degradable cross-linking agents and cross-linked network polymers formed therewith |
| 12/11/2002 | CN1384095A Prepn of water solution of unsaturated quaternary ammonium salt |
| 12/05/2002 | WO2002096855A2 Anticholinergic compounds and methods of use |
| 12/05/2002 | US20020183543 Process for preparing 2-(dimethylamino)-1-(dimethyl-aminomethyl) ethyl meth (acrylate) |
| 12/05/2002 | US20020183397 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 12/05/2002 | CA2443346A1 Anticholinergic compounds and methods of use |